CONMED Cash on Hand 2012-2026 | CNMD

CONMED cash on hand from 2012 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
CONMED Annual Cash on Hand
(Millions of US $)
2025 $41
2024 $24
2023 $24
2022 $29
2021 $21
2020 $27
2019 $26
2018 $18
2017 $33
2016 $27
2015 $73
2014 $66
2013 $54
2012 $24
2011 $26
CONMED Quarterly Cash on Hand
(Millions of US $)
2026-06-30 $37
2026-03-31 $35
2025-12-31 $41
2025-09-30 $39
2025-06-30 $34
2025-03-31 $35
2024-12-31 $24
2024-09-30 $38
2024-06-30 $29
2024-03-31 $34
2023-12-31 $24
2023-09-30 $31
2023-06-30 $28
2023-03-31 $26
2022-12-31 $29
2022-09-30 $33
2022-06-30 $53
2022-03-31 $25
2021-12-31 $21
2021-09-30 $32
2021-06-30 $46
2021-03-31 $37
2020-12-31 $27
2020-09-30 $36
2020-06-30 $35
2020-03-31 $24
2019-12-31 $26
2019-09-30 $30
2019-06-30 $23
2019-03-31 $23
2018-12-31 $18
2018-09-30 $30
2018-06-30 $23
2018-03-31 $21
2017-12-31 $33
2017-09-30 $44
2017-06-30 $40
2017-03-31 $35
2016-12-31 $27
2016-09-30 $27
2016-06-30 $23
2016-03-31 $20
2015-12-31 $73
2015-09-30 $65
2015-06-30 $62
2015-03-31 $66
2014-12-31 $66
2014-09-30 $65
2014-06-30 $60
2014-03-31 $56
2013-12-31 $54
2013-09-30 $50
2013-06-30 $38
2013-03-31 $32
2012-12-31 $24
2012-09-30 $20
2012-06-30 $16
2012-03-31 $19
2011-12-31 $26
2011-09-30 $40
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.409B $1.375B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $103.449B 21.74
Cardinal Health (CAH) United States $54.083B 20.65
Becton Dickinson (BDX) United States $50.107B 13.99
West Pharmaceutical Services (WST) United States $25.477B 42.59
Straumann Holding AG (SAUHY) Switzerland $18.194B 0.00
Align Technology (ALGN) United States $10.775B 16.66
Cooper (COO) United States $10.384B 11.85
Henry Schein (HSIC) United States $9.670B 16.34
Merit Medical Systems (MMSI) United States $5.143B 23.47
DENTSPLY SIRONA (XRAY) United States $2.021B 7.09
STAAR Surgical (STAA) United States $1.124B 35.02
Pro-Dex (PDEX) United States $0.230B 21.45
Lifevantage (LFVN) United States $0.077B 11.04